Bank of Baroda Shares Slide 3% After BR Shetty Files $15 Billion Lawsuit in Bombay High Court

Shares of state-owned Bank of Baroda dropped as much as 3% on Wednesday morning, dragging the lender among the prominent losers on benchmark indices after Indian-origin tycoon and NMC Healthcare founder B.R. Shetty filed a staggering $15 billion (approximately ₹1.32 lakh crore) damages lawsuit against the bank and 25 other co-defendants in the Bombay High Court.

The legal action stems from the high-profile collapse of Shetty’s West Asia-focused healthcare and remittance empire, including NMC Healthcare and UAE Exchange.

Anatomy of the $15 Billion Plaint

According to court filings submitted in Mumbai, Shetty has accused Bank of Baroda and former corporate executives of colluding to divert corporate funds, conceal financial liabilities, and subject him to liabilities based on loan guarantees bearing forged signatures.

The damages claimed by Shetty are structured across three primary heads:

• Direct damages: $5 billion sought jointly and severally from the defendants for alleged fraud, negligence, and siphoning of capital.
• Consequential damages: $5 billion sought jointly and severally, accompanied by an interest demand pegged at 18% per annum.
• Reputational damages: An additional $5 billion sought exclusively from Bank of Baroda to compensate for irreparable harm to personal reputation and commercial goodwill, including fallout from look-out circulars (LOCs) initiated against him.

The suit names Bank of Baroda, 10 of its current and former officers, former NMC and Finablr/UAE Exchange executives Prasanth Manghat and Promoth Manghat, their associates, and Indian entities including Avitis Super Speciality Hospitals and SMARD Building Solutions. Shetty claimed that he relinquished executive control of the business entities in 2017 and discovered only in 2020 that unauthorized transactions and forged paperwork were routed through his corporate and personal accounts.

Bank of Baroda Vows Firm Legal Defense

Responding to market queries, Bank of Baroda informed the stock exchanges that it had not been formally served with the court documents and dismissed the untested pleadings.

"The Bank has not been served with such a suit and cannot comment on the contents of pleadings which are untested in court. If and when the Bank is served, the Bank will defend the suit firmly and take all steps necessary to protect its interests," the lender stated in an exchange notification.

The filing follows a cross-border legal milestone earlier this year. In July 2026, Bank of Baroda agreed to a $600 million (around ₹5,700 crore) settlement with the joint administrators of NMC Healthcare in the UAE and the UK without any admission of wrongdoing, aiming to draw a line under years of multi-jurisdictional insolvency proceedings. In his petition, Shetty argued that the settlement pertained to the very credit lines in dispute.

Market Reaction and Investor Implications

On the National Stock Exchange (NSE) and BSE, Bank of Baroda shares came under sharp selling pressure, sliding over 3% in intraday trade.

Key Takeaways for Investors:

• Contingent Liability Concerns: Although market participants note that the astronomical $15 billion figure is unlikely to materialize as immediate liability without exhaustive judicial scrutiny, the sheer headline scale creates a sentiment drag on public sector banking counters.
• Legal Prolongation: While the July overseas settlement was viewed as a step toward closing legacy foreign loan burdens, this domestic lawsuit reopens litigation risks in Indian courts.
• Earnings & Provisioning Watch: D-Street analysts will closely track the lender's disclosures during upcoming quarterly earnings to see if any contingent provisions or disclosures are added in connection with the Bombay High Court suit.

Tags: Bank of Baroda BSE NSE Nifty PSU Bank Reserve Bank of India Bombay High Court